Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | rHuPH20 |
Trade Name | |
Synonyms | Hylenex |
Drug Descriptions |
rHuPH20 is recombinant human hyaluronidase lacking the GPI anchor domain, which may enhance dispersion of substances delivered subcutaneously (PMID: 25967925, PMID: 16876899, PMID: 30744432). |
DrugClasses | |
CAS Registry Number | 757971-58-7 |
NCIT ID | C61504 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Amivantamab-vmjw + Lazertinib + rHuPH20 | Amivantamab-vmjw Lazertinib rHuPH20 | 0 | 1 |
Amivantamab-vmjw + rHuPH20 | Amivantamab-vmjw rHuPH20 | 0 | 1 |
Atezolizumab + rHuPH20 | Atezolizumab rHuPH20 | 0 | 2 |
Daratumumab + Lenalidomide + rHuPH20 | Daratumumab Lenalidomide rHuPH20 | 0 | 1 |
Daratumumab + rHuPH20 | Daratumumab rHuPH20 | 0 | 2 |
Ipilimumab + Nivolumab + rHuPH20 | Ipilimumab Nivolumab rHuPH20 | 0 | 1 |
Nivolumab + Relatlimab + rHuPH20 | Nivolumab Relatlimab rHuPH20 | 0 | 2 |
Nivolumab + rHuPH20 | Nivolumab rHuPH20 | 0 | 2 |
rHuPH20 | rHuPH20 | 0 | 0 |